L008 Pill - white capsule/oblong, 19mm
Pill with imprint L008 is White, Capsule/Oblong and has been identified as Levetiracetam Extended Release 500 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L008





Levetiracetam Extended Release
- Imprint
- L008
- Strength
- 500 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0117
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
lactose anhydrous,
silicon dioxide,
hypromellose 2910 (5 mPa.s),
hydrogenated cottonseed oil,
shellac,
magnesium silicate,
magnesium stearate,
polyethylene glycol,
propylene glycol,
titanium dioxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "L008"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (430)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Injection
- Levetiracetam Tablets
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.